They suspended the production of medicines from a laboratory and ordered the removal of their products from the market following a bacterial outbreak.

A batch of fentanyl linked to 18 affected patients triggered an operation against HLB Pharma. Scandals include serious failures in essential drugs and complicated court records of its managers

The deaths from the use of contaminated fentanyl in institutions of the public and private health system of Argentina added a chapter this Tuesday when it was confirmed that the government ordered the suspension of activities in the two plants belonging to the HLB Pharma Group laboratory, which produced the compound that generated an ongoing outbreak of serious invasive infections associated with its use. [...] The entry The ANMAT suspended the …

Dragosh Damian, director of the Master of the Romanian Industrial Medicines Manufacturers (PRIMER) explained to News.ro the phenomenon that may have a place on the market if their euro-level course is going to grow much. Thus, says PRIMER, for producers, certain medicines, especially those of the generic category – if it could become useless and could then remove those products from production, calling for what happened in Hungary, during which …

Nine patients who were hospitalized in intensive care in a hospital in La Plata died in the context of an outbreak of pneumonia that, according to the National Administration of Medicines, Food and Medical Technology (ANMAT), would be related to a consignment of contaminated fentanyl.The substance, used for medical purposes, was elaborated by the laboratory HLB Pharma Group S.A. and its associated firm, Laboratorios Ramallo S.A., on which measur…

A new report by the Ministry of Health, prepared by the Directorate of Epidemiology and the Malbrán Institute, confirmed an outbreak of toxic origin linked to the use of fentanyl ampoules from the HLB Pharma Group S.A. laboratory, which would have caused the death of nine people in La Plata. The substance was contaminated with two highly dangerous bacteria and contained undeclared components, which triggered a national epidemiological alert. The…

The disqualified firm is linked to a batch of a drug identified as "Fentanilo HLB", which caused diseases to 18 patients in different cities in the interior, nine of whom were seriously hospitalized The National Administration of Medicines, Food and Medical Technology (ANMAT) inhibited the productive activities of medicines and other inputs of the company HLB Pharma Group S.A. and its related firm, Laboratorios Ramallo, and suspended the marketi…